Comparison Between Topical Mitomycin C and Cyclosporine After Primary Pterygium Surgery

OMNEYA HEGAZY

Pterygium is a disease associated with proliferation of the fibrovascular tissues of the conjunctiva into the cornea and is related to factors such as ultraviolet light exposure, chronic stimulation, inflammation, climate, and genetics.

2021-01-01

2022-06-15

2022-06-30

Completed

Early phase I

57

Inclusion Criteria: * Diagnosis of primary pterygium * Pterygium size \> or equal 2mm (the horizontal length of the tissue from limbus to cornea will be measured by slit lamp biomicroscopy). * Ocular discomfort refractory to medical treatment. * Visual loss induced by pterygium. * Adult Egyptian population Exclusion Criteria: * Patients who had recurrent pterygium or allergy to topical Cyclosporine. * Patients who had allergy from Mitomycin C. * Pregnant women. * Patients with uncontrollable systemic diseases such as hypertension, diabetes, or cardiovascular diseases. * Patients with diseases of the eye surface such as conjunctivitis and keratitis. * Patients with a history of eye surgery within the previous six months.

{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE1'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'compare the recurrence rates and complications associated with instillation of topical mitomycin C and cyclosporine after primary pterygium surgery', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 57, 'type': 'ACTUAL'}}

2023-10-17